2018
DOI: 10.1183/13993003.01118-2018
|View full text |Cite
|
Sign up to set email alerts
|

Myeloperoxidase oxidation of methionine associates with early cystic fibrosis lung disease

Abstract: Cystic fibrosis (CF) lung disease progressively worsens from infancy to adulthood. Disease-driven changes in early CF airway fluid metabolites may identify therapeutic targets to curb progression.CF patients aged 12-38 months (n=24; three out of 24 later denoted as CF screen positive, inconclusive diagnosis) received chest computed tomography scans, scored by the Perth-Rotterdam Annotated Grid Morphometric Analysis for CF (PRAGMA-CF) method to quantify total lung disease (PRAGMA-%Dis) and components such as br… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
36
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 45 publications
(38 citation statements)
references
References 49 publications
(60 reference statements)
2
36
0
Order By: Relevance
“…NET presence was found to be elevated in acute respiratory distress syndrome (ARDS) patients with ventilator-associated pneumonia compared to ARDS alone, and correlated with both bacterial burden and CXCL8 [81]. Considering that MPO has been found to be elevated in the airways of ARDS patients [82] and that this enzyme is associated with lung damage in CF [83,84], NET-associated MPO may be a contributing factor in progression of disease in ARDS. Studies of NETosis are also contributing to a better understanding of neutrophil plasticity.…”
Section: Bacterial Infectionsmentioning
confidence: 99%
“…NET presence was found to be elevated in acute respiratory distress syndrome (ARDS) patients with ventilator-associated pneumonia compared to ARDS alone, and correlated with both bacterial burden and CXCL8 [81]. Considering that MPO has been found to be elevated in the airways of ARDS patients [82] and that this enzyme is associated with lung damage in CF [83,84], NET-associated MPO may be a contributing factor in progression of disease in ARDS. Studies of NETosis are also contributing to a better understanding of neutrophil plasticity.…”
Section: Bacterial Infectionsmentioning
confidence: 99%
“…Before the discovery of NETosis (controlled neutrophil cell death with the release of NETs), necrosis was generally considered to be the primary source of neutrophil DNA in the lungs of patients with CF; however, this was subsequently revealed not to be the case, as NETosis was shown to be responsible for the release of myeloperoxidase (MPO), heparin-binding protein (HBP), DNA and NE in CF sputum and bronchoalveolar lavage fluid (BALF) [132][133][134][135]. As the high concentration of inflammatory markers and these proteins, both in the CF sputum and BALF, correlates with decreasing lung function, NETosis plays an essential role in the pathogenesis of CF [132,134,[136][137][138][139][140][141][142][143][144][145][146]. The raised levels of NE and cathepsin G have been suggested to be responsible for increased levels of peptides and amino acids in sputum samples, whilst the raised concentrations of these peptides and amino acids correlate with increased frequency of P. aeruginosa infection in the lungs of patients with CF [147].…”
Section: Neutrophilsmentioning
confidence: 99%
“…Infiltrated neutrophils either phagocytose microbial pathogens and generate reactive oxygen species (ROS) for intracellular killing, or degranulate to release cytotoxic peptides for extracellular killing, or cast NETs as a DNA-mesh to ensnare microbial pathogens [26,27,28]. During NETosis, neutrophils release, decondensed chromatin coated with elastase, myeloperoxidase (MPO), and other cytotoxic granular proteases [12,27,29,30,31,32]. These neutrophil components perpetuate severe inflammation that characterizes CF lung disease [10,11,31,33,34,35].…”
Section: Introductionmentioning
confidence: 99%